Japanese Pharmacology & Therapeutics (JPT)
Vol. 46 Suppl. 1 2018
■REVIEW Countermeasures for “Clinical Trials Act”
Point of “Clinical Trials Act”
H. Ohtsu
Jpn Pharmacol Ther 2018 46(s1) s6
Subsequent Events of Results of the Questionnaire about Clinical Trials Act that Members of the Japan Society of Clinical Trials and Research Replied
H. Taruno
Jpn Pharmacol Ther 2018 46(s1) s9
The Handbook Dealing with Clinical Trials Act for Principal Investigators
Y.Ohashi and H. Taruno
Jpn Pharmacol Ther 2018 46(s1) s14
How Do We Manage the Clinical Research Act as Academia?
Shine a Light on “the Elephant in the Dark”
H. Yamamoto
Jpn Pharmacol Ther 2018 46(s1) s19
How Do We Cope with the Clinical Research Act as a Multicenter Clinical Trial Group?
K.Nakamura
Jpn Pharmacol Ther 2018 46(s1) s23